
Oncology NEWS International
- Oncology NEWS International Vol 5 No 7
 - Volume 5
 - Issue 7
 
NCI Acts as Catalyst for New Middle East Cancer Consortium
BETHESDA, Md--The National Cancer Institute has orchestrated an agreement between the Ministers of Health of Cyprus, Egypt, Israel, Jordan, and the Palestinian Authority. The five ministers recently gathered in Geneva to sign the Middle East Cancer Consortium (MECC) agreement.
BETHESDA, Md--The National Cancer Institute has orchestrated anagreement between the Ministers of Health of Cyprus, Egypt, Israel,Jordan, and the Palestinian Authority. The five ministers recentlygathered in Geneva to sign the Middle East Cancer Consortium (MECC)agreement.
Witnessing the signing were Donna Shalala, Secretary of Healthand Human Services, and NCI Director Richard Klausner. AlthoughMECC funding will come from its members, the NIH will also contributeinitial financial support.
The MECC will focus on cancer surveillance, information, and education.This is extremely important since few countries in the MiddleEast maintain cancer registries, the NCI said.
The MECC will also work to improve physician training, conductbasic and clinical research, enhance public health and patientcare, institute quality control programs, and develop guidelinesand protocols. Other countries in the Middle East are free tojoin the Consortium in the future.
Articles in this issue
over 29 years ago
Princess Diana Helps Raise Over $1 Million for Cancer Researchover 29 years ago
Study Gives Terminal Patients Option: $18,000 or More Treatmentover 29 years ago
Proven: Colorectal Screening Cuts Deaths 50%over 29 years ago
Virtual Colonoscopy Technique Feasible in Detecting Polypsover 29 years ago
Trimetrexate Appears Beneficial in Colorectal Cancerover 29 years ago
FDA Liaison Program Answers Patients' Questions About Trialsover 29 years ago
New Company Joins With RPR To Develop Intrabody Technologyover 29 years ago
More Insurers Covering ABMT, Despite Lack of Efficacy Dataover 29 years ago
CDC Says Teen Smoking Still RisingNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.



















































































